Nov.19 -- The University of Oxford confirmed that the Covid-19 vaccine it’s developing with AstraZeneca Plc produced strong immune responses in older adults in an early study, with pivotal findings from the final phase of trials expected in the coming weeks. Bloomberg Intelligence's Sam Fazeli has the details on "Bloomberg Markets: European Open."